Professor Brian T. Cunningham recently received a grant through the National Institutes of Health (NIH) Innovative Molecular Analysis Technologies Program, to develop biosensing equipment for early-stage detection of breast cancer and for human papillomavirus, a common precipitate of cervical cancer. Both diseases could be detected with just a minute amount of blood.
